Rank | Gene Set | Z-score |
---|---|---|
1 | neuron cell-cell adhesion (GO:0007158) | 5.37637608 |
2 | vocalization behavior (GO:0071625) | 5.05804406 |
3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.65876345 |
4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.50460187 |
5 | neuron recognition (GO:0008038) | 4.49403201 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.42746221 |
7 | synaptic vesicle exocytosis (GO:0016079) | 4.40765978 |
8 | protein localization to synapse (GO:0035418) | 4.38021774 |
9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.29852127 |
10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.21743486 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.16992476 |
12 | dendritic spine morphogenesis (GO:0060997) | 4.11329035 |
13 | locomotory exploration behavior (GO:0035641) | 4.10624991 |
14 | presynaptic membrane assembly (GO:0097105) | 4.07714598 |
15 | * glutamate receptor signaling pathway (GO:0007215) | 4.04347370 |
16 | axonal fasciculation (GO:0007413) | 4.00608934 |
17 | nerve growth factor signaling pathway (GO:0038180) | 3.97639147 |
18 | exploration behavior (GO:0035640) | 3.90508742 |
19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.86248504 |
20 | neuronal action potential propagation (GO:0019227) | 3.83688514 |
21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.82606628 |
22 | presynaptic membrane organization (GO:0097090) | 3.82145940 |
23 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.76671153 |
24 | glutamate secretion (GO:0014047) | 3.75303835 |
25 | layer formation in cerebral cortex (GO:0021819) | 3.73208406 |
26 | synaptic vesicle maturation (GO:0016188) | 3.66004622 |
27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.64247540 |
28 | synaptic transmission, glutamatergic (GO:0035249) | 3.61389286 |
29 | neuron-neuron synaptic transmission (GO:0007270) | 3.59602813 |
30 | postsynaptic membrane organization (GO:0001941) | 3.58205237 |
31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.53140916 |
32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.45559314 |
33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.43353487 |
34 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.42862004 |
35 | regulation of synaptic vesicle transport (GO:1902803) | 3.39012566 |
36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.37258575 |
37 | transmission of nerve impulse (GO:0019226) | 3.33027380 |
38 | cell migration in hindbrain (GO:0021535) | 3.30431352 |
39 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.29385999 |
40 | interkinetic nuclear migration (GO:0022027) | 3.28695279 |
41 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.28638805 |
42 | neurotransmitter secretion (GO:0007269) | 3.27171048 |
43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.23114585 |
44 | dendrite morphogenesis (GO:0048813) | 3.20816981 |
45 | positive regulation of synapse assembly (GO:0051965) | 3.17928064 |
46 | regulation of vesicle fusion (GO:0031338) | 3.17177655 |
47 | innervation (GO:0060384) | 3.15058095 |
48 | long-term memory (GO:0007616) | 3.13442274 |
49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.11821534 |
50 | negative regulation of neurotransmitter transport (GO:0051589) | 3.10974099 |
51 | regulation of synapse structural plasticity (GO:0051823) | 3.09104767 |
52 | synapse assembly (GO:0007416) | 3.09000583 |
53 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.08158412 |
54 | long-term synaptic potentiation (GO:0060291) | 3.07167011 |
55 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.06388936 |
56 | dendritic spine organization (GO:0097061) | 3.06054283 |
57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05272597 |
58 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.04892715 |
59 | synaptic vesicle endocytosis (GO:0048488) | 3.04827396 |
60 | proline transport (GO:0015824) | 3.03252959 |
61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.01779818 |
62 | regulation of dendritic spine development (GO:0060998) | 3.01538332 |
63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.99012368 |
64 | regulation of glutamate secretion (GO:0014048) | 2.97264534 |
65 | positive regulation of membrane potential (GO:0045838) | 2.96182975 |
66 | regulation of synaptic plasticity (GO:0048167) | 2.94657076 |
67 | neurotransmitter transport (GO:0006836) | 2.93821427 |
68 | gamma-aminobutyric acid transport (GO:0015812) | 2.92451672 |
69 | response to histamine (GO:0034776) | 2.92415620 |
70 | mating behavior (GO:0007617) | 2.91926505 |
71 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.91162612 |
72 | startle response (GO:0001964) | 2.87295399 |
73 | auditory behavior (GO:0031223) | 2.87234793 |
74 | learning (GO:0007612) | 2.87107677 |
75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.86387066 |
76 | membrane depolarization (GO:0051899) | 2.85464999 |
77 | positive regulation of dendritic spine development (GO:0060999) | 2.84973176 |
78 | regulation of respiratory system process (GO:0044065) | 2.81093985 |
79 | negative regulation of microtubule polymerization (GO:0031115) | 2.81010799 |
80 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.80974627 |
81 | cell differentiation in hindbrain (GO:0021533) | 2.79827627 |
82 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.79168163 |
83 | regulation of neurotransmitter secretion (GO:0046928) | 2.78897592 |
84 | synapse organization (GO:0050808) | 2.78567528 |
85 | positive regulation of synapse maturation (GO:0090129) | 2.78154873 |
86 | cerebellar granule cell differentiation (GO:0021707) | 2.76435095 |
87 | nucleobase catabolic process (GO:0046113) | 2.76420638 |
88 | behavioral fear response (GO:0001662) | 2.75311893 |
89 | behavioral defense response (GO:0002209) | 2.75311893 |
90 | fear response (GO:0042596) | 2.73250371 |
91 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.73116991 |
92 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.72949871 |
93 | organelle transport along microtubule (GO:0072384) | 2.72768052 |
94 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.72211713 |
95 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.71667591 |
96 | vesicle transport along microtubule (GO:0047496) | 2.71369277 |
97 | regulation of synapse assembly (GO:0051963) | 2.71345774 |
98 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.70700567 |
99 | mechanosensory behavior (GO:0007638) | 2.70263054 |
100 | detection of calcium ion (GO:0005513) | 2.69410158 |
101 | dendrite development (GO:0016358) | 2.69222902 |
102 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.66520298 |
103 | cellular potassium ion homeostasis (GO:0030007) | 2.66387463 |
104 | potassium ion homeostasis (GO:0055075) | 2.66326475 |
105 | adult walking behavior (GO:0007628) | 2.64794424 |
106 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.64114782 |
107 | regulation of neurotransmitter levels (GO:0001505) | 2.63888236 |
108 | membrane hyperpolarization (GO:0060081) | 2.63434961 |
109 | intraspecies interaction between organisms (GO:0051703) | 2.62559914 |
110 | social behavior (GO:0035176) | 2.62559914 |
111 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.60035290 |
112 | regulation of respiratory gaseous exchange (GO:0043576) | 2.59654136 |
113 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.58404176 |
114 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.58170959 |
115 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.56694526 |
116 | regulation of neurotransmitter transport (GO:0051588) | 2.55939737 |
117 | membrane depolarization during action potential (GO:0086010) | 2.53607623 |
118 | regulation of female receptivity (GO:0045924) | 2.52791167 |
119 | nucleus localization (GO:0051647) | 2.50117598 |
120 | negative regulation of dendrite development (GO:2000171) | 2.48027656 |
121 | negative regulation of exocytosis (GO:0045920) | 2.47529301 |
122 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.46413250 |
123 | central nervous system myelination (GO:0022010) | 2.45934102 |
124 | axon ensheathment in central nervous system (GO:0032291) | 2.45934102 |
125 | female mating behavior (GO:0060180) | 2.44007804 |
126 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.44003725 |
127 | regulation of exocytosis (GO:0017157) | 2.43330129 |
128 | potassium ion import (GO:0010107) | 2.42417394 |
129 | serotonin metabolic process (GO:0042428) | 2.42234763 |
130 | relaxation of smooth muscle (GO:0044557) | 2.41250815 |
131 | L-amino acid import (GO:0043092) | 2.39618537 |
132 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.39122730 |
133 | membrane assembly (GO:0071709) | 2.38525442 |
134 | dopamine biosynthetic process (GO:0042416) | 2.36839987 |
135 | definitive hemopoiesis (GO:0060216) | 2.36516373 |
136 | establishment of nucleus localization (GO:0040023) | 2.31502830 |
137 | apical protein localization (GO:0045176) | 2.31459408 |
138 | positive regulation of meiosis (GO:0045836) | 2.27975349 |
139 | neuronal action potential (GO:0019228) | 2.25938716 |
140 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.25442195 |
141 | sodium ion export (GO:0071436) | 2.22510368 |
142 | regulation of Rap GTPase activity (GO:0032317) | 2.22224212 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.62721125 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.78503788 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00360399 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98821853 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94608361 |
6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60184202 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56257554 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56257554 |
9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53016362 |
10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51924223 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48298637 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45798716 |
13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36522733 |
14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32537378 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25817178 |
16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24310761 |
17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23346209 |
18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07518663 |
19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05328668 |
20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05318969 |
21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04573506 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03064769 |
23 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01147841 |
24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.00127091 |
25 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.93000493 |
26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84445638 |
27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81020946 |
28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81005978 |
29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74508076 |
30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73871591 |
31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72245030 |
32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69728065 |
33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67358435 |
34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63196069 |
35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62290053 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61458750 |
37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61244473 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59943997 |
39 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59280972 |
40 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59041614 |
41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58668516 |
42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55939651 |
43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55871369 |
44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54529681 |
45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51796689 |
46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51241278 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51188141 |
48 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51075430 |
49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49781093 |
50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49054576 |
51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46718394 |
52 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45578043 |
53 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45060788 |
54 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44964032 |
55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41748064 |
56 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.36103305 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35590269 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35590269 |
59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32676459 |
60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30202310 |
61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29288429 |
62 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27274486 |
63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27114138 |
64 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25883445 |
65 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25630828 |
66 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25593637 |
67 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25025004 |
68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24057241 |
69 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22867512 |
70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22191792 |
71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20780169 |
72 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19127557 |
73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18400122 |
74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17748948 |
75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17713095 |
76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17671825 |
77 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.17548250 |
78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17113528 |
79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14537218 |
80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14438638 |
81 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13682316 |
82 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13672785 |
83 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13043271 |
84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10102417 |
85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10030456 |
86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09859828 |
87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08681926 |
88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08062011 |
89 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07981561 |
90 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07981561 |
91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07794032 |
92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07549208 |
93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07491132 |
94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06945033 |
95 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06576506 |
96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06204518 |
97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05534598 |
98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05400345 |
99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05299532 |
100 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.04380288 |
101 | JUN_21703547_ChIP-Seq_K562_Human | 1.04144215 |
102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03939245 |
103 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03433762 |
104 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02799247 |
105 | AR_19668381_ChIP-Seq_PC3_Human | 1.02570129 |
106 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02473072 |
107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01816263 |
108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01768734 |
109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01625425 |
110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95350047 |
111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94523592 |
112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93393023 |
113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91945213 |
114 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.91691711 |
115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91270417 |
116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91036460 |
117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90821957 |
118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90642834 |
119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90601120 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.30198160 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.12679517 |
3 | MP0004270_analgesia | 3.92051386 |
4 | * MP0003635_abnormal_synaptic_transmissio | 3.65335756 |
5 | MP0001968_abnormal_touch/_nociception | 3.23040316 |
6 | MP0009745_abnormal_behavioral_response | 3.10123738 |
7 | MP0002063_abnormal_learning/memory/cond | 3.05647023 |
8 | MP0002735_abnormal_chemical_nociception | 2.87607290 |
9 | MP0002064_seizures | 2.87403676 |
10 | MP0002734_abnormal_mechanical_nocicepti | 2.80604420 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.73058226 |
12 | MP0002736_abnormal_nociception_after | 2.72406171 |
13 | MP0009046_muscle_twitch | 2.60148376 |
14 | MP0006276_abnormal_autonomic_nervous | 2.53557145 |
15 | MP0005423_abnormal_somatic_nervous | 2.51403796 |
16 | * MP0002272_abnormal_nervous_system | 2.45672240 |
17 | MP0000778_abnormal_nervous_system | 2.44043295 |
18 | MP0001486_abnormal_startle_reflex | 2.39445036 |
19 | MP0001440_abnormal_grooming_behavior | 2.32256369 |
20 | MP0002733_abnormal_thermal_nociception | 2.28650096 |
21 | MP0001970_abnormal_pain_threshold | 2.15022781 |
22 | MP0001501_abnormal_sleep_pattern | 2.12559482 |
23 | MP0002067_abnormal_sensory_capabilities | 2.03646246 |
24 | * MP0002184_abnormal_innervation | 1.99118003 |
25 | MP0001529_abnormal_vocalization | 1.90665445 |
26 | MP0003329_amyloid_beta_deposits | 1.87943168 |
27 | MP0003724_increased_susceptibility_to | 1.81915211 |
28 | MP0001905_abnormal_dopamine_level | 1.76943733 |
29 | MP0009780_abnormal_chondrocyte_physiolo | 1.75106804 |
30 | MP0002557_abnormal_social/conspecific_i | 1.72618036 |
31 | MP0005386_behavior/neurological_phenoty | 1.70587074 |
32 | MP0004924_abnormal_behavior | 1.70587074 |
33 | MP0004858_abnormal_nervous_system | 1.65276146 |
34 | MP0002822_catalepsy | 1.64836831 |
35 | MP0000955_abnormal_spinal_cord | 1.58960462 |
36 | MP0004811_abnormal_neuron_physiology | 1.54986951 |
37 | MP0002882_abnormal_neuron_morphology | 1.48710927 |
38 | MP0005187_abnormal_penis_morphology | 1.45956173 |
39 | MP0001984_abnormal_olfaction | 1.45276791 |
40 | MP0005645_abnormal_hypothalamus_physiol | 1.45009812 |
41 | MP0004742_abnormal_vestibular_system | 1.43922850 |
42 | MP0003183_abnormal_peptide_metabolism | 1.42350384 |
43 | MP0008569_lethality_at_weaning | 1.37356883 |
44 | * MP0002066_abnormal_motor_capabilities/c | 1.36258852 |
45 | MP0010386_abnormal_urinary_bladder | 1.31633914 |
46 | MP0004885_abnormal_endolymph | 1.31553457 |
47 | MP0002837_dystrophic_cardiac_calcinosis | 1.30363157 |
48 | MP0002909_abnormal_adrenal_gland | 1.30187732 |
49 | MP0001851_eye_inflammation | 1.27785847 |
50 | MP0001502_abnormal_circadian_rhythm | 1.27569178 |
51 | MP0000920_abnormal_myelination | 1.25845033 |
52 | MP0003122_maternal_imprinting | 1.25739852 |
53 | MP0005646_abnormal_pituitary_gland | 1.24898536 |
54 | MP0004142_abnormal_muscle_tone | 1.18273061 |
55 | MP0008877_abnormal_DNA_methylation | 1.16416200 |
56 | MP0003633_abnormal_nervous_system | 1.15955434 |
57 | MP0003787_abnormal_imprinting | 1.14193181 |
58 | MP0003890_abnormal_embryonic-extraembry | 1.13808588 |
59 | MP0003634_abnormal_glial_cell | 1.13209233 |
60 | MP0000383_abnormal_hair_follicle | 1.12148749 |
61 | MP0002152_abnormal_brain_morphology | 1.12027260 |
62 | MP0010368_abnormal_lymphatic_system | 1.11419768 |
63 | MP0003631_nervous_system_phenotype | 1.07392400 |
64 | MP0004130_abnormal_muscle_cell | 1.06799412 |
65 | MP0004145_abnormal_muscle_electrophysio | 1.03731182 |
66 | MP0003283_abnormal_digestive_organ | 1.03464692 |
67 | MP0004883_abnormal_blood_vessel | 1.01906743 |
68 | MP0005171_absent_coat_pigmentation | 1.01698269 |
69 | MP0003879_abnormal_hair_cell | 1.01048390 |
70 | MP0002229_neurodegeneration | 1.00284435 |
71 | MP0005248_abnormal_Harderian_gland | 0.97822867 |
72 | MP0010678_abnormal_skin_adnexa | 0.96429158 |
73 | MP0005551_abnormal_eye_electrophysiolog | 0.96318701 |
74 | MP0001963_abnormal_hearing_physiology | 0.95753430 |
75 | MP0002752_abnormal_somatic_nervous | 0.95712050 |
76 | MP0000465_gastrointestinal_hemorrhage | 0.94170600 |
77 | MP0003121_genomic_imprinting | 0.93743499 |
78 | MP0000631_abnormal_neuroendocrine_gland | 0.92978508 |
79 | MP0002009_preneoplasia | 0.92139650 |
80 | MP0005084_abnormal_gallbladder_morpholo | 0.90595829 |
81 | MP0002928_abnormal_bile_duct | 0.90239549 |
82 | MP0000604_amyloidosis | 0.90174409 |
83 | * MP0005464_abnormal_platelet_physiology | 0.89721319 |
84 | MP0004043_abnormal_pH_regulation | 0.89669001 |
85 | MP0003632_abnormal_nervous_system | 0.89144513 |
86 | MP0003828_pulmonary_edema | 0.88943878 |
87 | MP0005595_abnormal_vascular_smooth | 0.87815287 |
88 | MP0000751_myopathy | 0.87430290 |
89 | MP0002069_abnormal_eating/drinking_beha | 0.85543169 |
90 | MP0003690_abnormal_glial_cell | 0.85399363 |
91 | MP0004133_heterotaxia | 0.83202863 |
92 | MP0002876_abnormal_thyroid_physiology | 0.83179873 |
93 | MP0000569_abnormal_digit_pigmentation | 0.82524334 |
94 | MP0002133_abnormal_respiratory_system | 0.82520293 |
95 | MP0005388_respiratory_system_phenotype | 0.82520293 |
96 | MP0004484_altered_response_of | 0.81914225 |
97 | MP0004085_abnormal_heartbeat | 0.81436579 |
98 | MP0001485_abnormal_pinna_reflex | 0.81304979 |
99 | MP0005167_abnormal_blood-brain_barrier | 0.80304029 |
100 | * MP0001188_hyperpigmentation | 0.79097365 |
101 | MP0005535_abnormal_body_temperature | 0.78907197 |
102 | MP0001177_atelectasis | 0.78645574 |
103 | MP0002638_abnormal_pupillary_reflex | 0.78147882 |
104 | MP0000013_abnormal_adipose_tissue | 0.77004820 |
105 | MP0001299_abnormal_eye_distance/ | 0.76934590 |
106 | MP0000026_abnormal_inner_ear | 0.75470120 |
107 | MP0008004_abnormal_stomach_pH | 0.74797843 |
108 | MP0002751_abnormal_autonomic_nervous | 0.74655945 |
109 | MP0006072_abnormal_retinal_apoptosis | 0.73880972 |
110 | MP0000230_abnormal_systemic_arterial | 0.73850279 |
111 | MP0005499_abnormal_olfactory_system | 0.73418361 |
112 | MP0005394_taste/olfaction_phenotype | 0.73418361 |
113 | MP0008057_abnormal_DNA_replication | 0.72248456 |
114 | MP0003638_abnormal_response/metabolism_ | 0.72165537 |
115 | MP0004134_abnormal_chest_morphology | 0.71720102 |
116 | MP0003861_abnormal_nervous_system | 0.66866239 |
117 | MP0002090_abnormal_vision | 0.66713670 |
118 | MP0008874_decreased_physiological_sensi | 0.66290660 |
119 | MP0003303_peritoneal_inflammation | 0.64722256 |
120 | MP0001943_abnormal_respiration | 0.64706661 |
121 | MP0002160_abnormal_reproductive_system | 0.64705582 |
122 | MP0005623_abnormal_meninges_morphology | 0.64522799 |
123 | MP0001879_abnormal_lymphatic_vessel | 0.63807504 |
124 | MP0003938_abnormal_ear_development | 0.63175211 |
125 | MP0001664_abnormal_digestion | 0.62013916 |
126 | MP0005379_endocrine/exocrine_gland_phen | 0.58737601 |
127 | MP0002102_abnormal_ear_morphology | 0.57902804 |
128 | MP0008872_abnormal_physiological_respon | 0.57698638 |
129 | MP0003136_yellow_coat_color | 0.54357809 |
130 | MP0001986_abnormal_taste_sensitivity | 0.53001056 |
131 | MP0000538_abnormal_urinary_bladder | 0.51812605 |
132 | MP0003137_abnormal_impulse_conducting | 0.51538429 |
133 | MP0004215_abnormal_myocardial_fiber | 0.51139937 |
134 | MP0005195_abnormal_posterior_eye | 0.50056765 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.72674023 |
2 | Myokymia (HP:0002411) | 5.25612236 |
3 | Focal seizures (HP:0007359) | 5.09159126 |
4 | Atonic seizures (HP:0010819) | 4.51884689 |
5 | Visual hallucinations (HP:0002367) | 4.39406256 |
6 | Papillary thyroid carcinoma (HP:0002895) | 4.38700781 |
7 | Epileptic encephalopathy (HP:0200134) | 4.29433401 |
8 | Hyperventilation (HP:0002883) | 3.91939185 |
9 | Progressive cerebellar ataxia (HP:0002073) | 3.89723464 |
10 | Febrile seizures (HP:0002373) | 3.88805470 |
11 | Neurofibrillary tangles (HP:0002185) | 3.85995083 |
12 | Cerebral inclusion bodies (HP:0100314) | 3.81944586 |
13 | Absence seizures (HP:0002121) | 3.79580428 |
14 | Metaphyseal dysplasia (HP:0100255) | 3.66457134 |
15 | Supranuclear gaze palsy (HP:0000605) | 3.66359847 |
16 | Dialeptic seizures (HP:0011146) | 3.59958936 |
17 | Action tremor (HP:0002345) | 3.58423262 |
18 | Broad-based gait (HP:0002136) | 3.43279905 |
19 | Insidious onset (HP:0003587) | 3.43267543 |
20 | Termporal pattern (HP:0011008) | 3.43267543 |
21 | Generalized tonic-clonic seizures (HP:0002069) | 3.42729034 |
22 | Amblyopia (HP:0000646) | 3.38625032 |
23 | Abnormality of the corticospinal tract (HP:0002492) | 3.30075945 |
24 | Excessive salivation (HP:0003781) | 3.23531961 |
25 | Drooling (HP:0002307) | 3.23531961 |
26 | Limb dystonia (HP:0002451) | 3.09001816 |
27 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.06268245 |
28 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.06268245 |
29 | Mutism (HP:0002300) | 3.04099402 |
30 | Thyroid carcinoma (HP:0002890) | 3.02339818 |
31 | Absent speech (HP:0001344) | 2.89685231 |
32 | Progressive inability to walk (HP:0002505) | 2.83640845 |
33 | Truncal ataxia (HP:0002078) | 2.72312574 |
34 | Dysmetria (HP:0001310) | 2.70630730 |
35 | Anxiety (HP:0000739) | 2.67440139 |
36 | Ankle clonus (HP:0011448) | 2.64299463 |
37 | Hemiparesis (HP:0001269) | 2.60211493 |
38 | Abnormal eating behavior (HP:0100738) | 2.53168499 |
39 | Prolonged bleeding time (HP:0003010) | 2.51473542 |
40 | Pheochromocytoma (HP:0002666) | 2.50384035 |
41 | Gaze-evoked nystagmus (HP:0000640) | 2.48197254 |
42 | Abnormality of binocular vision (HP:0011514) | 2.46949746 |
43 | Diplopia (HP:0000651) | 2.46949746 |
44 | Epileptiform EEG discharges (HP:0011182) | 2.46514792 |
45 | Dysdiadochokinesis (HP:0002075) | 2.45615841 |
46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43131013 |
47 | Polyphagia (HP:0002591) | 2.40871405 |
48 | Spastic gait (HP:0002064) | 2.40141288 |
49 | Exotropia (HP:0000577) | 2.38011245 |
50 | Hemiplegia (HP:0002301) | 2.36796189 |
51 | Abnormality of salivation (HP:0100755) | 2.36777069 |
52 | Poor eye contact (HP:0000817) | 2.32370447 |
53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.32027871 |
54 | Gait imbalance (HP:0002141) | 2.31936710 |
55 | Acute myeloid leukemia (HP:0004808) | 2.31389450 |
56 | Agitation (HP:0000713) | 2.29412753 |
57 | Ulnar claw (HP:0001178) | 2.29144971 |
58 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.25032978 |
59 | Retinal dysplasia (HP:0007973) | 2.24141357 |
60 | Depression (HP:0000716) | 2.19685024 |
61 | Urinary urgency (HP:0000012) | 2.18786381 |
62 | Inability to walk (HP:0002540) | 2.16765374 |
63 | Hypsarrhythmia (HP:0002521) | 2.15828207 |
64 | Neuroendocrine neoplasm (HP:0100634) | 2.14201595 |
65 | Inappropriate behavior (HP:0000719) | 2.12069587 |
66 | Blue irides (HP:0000635) | 2.11987231 |
67 | Impaired social interactions (HP:0000735) | 2.09948807 |
68 | Abnormal social behavior (HP:0012433) | 2.09948807 |
69 | Disinhibition (HP:0000734) | 2.09922246 |
70 | Scanning speech (HP:0002168) | 2.09343276 |
71 | Protruding tongue (HP:0010808) | 2.07729399 |
72 | Lower limb muscle weakness (HP:0007340) | 2.07436991 |
73 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07316412 |
74 | Stereotypic behavior (HP:0000733) | 2.07091900 |
75 | Akinesia (HP:0002304) | 2.06326330 |
76 | Thickened helices (HP:0000391) | 2.05481227 |
77 | Genetic anticipation (HP:0003743) | 2.05357798 |
78 | Papilledema (HP:0001085) | 2.05147679 |
79 | Peripheral hypomyelination (HP:0007182) | 2.03686115 |
80 | Generalized myoclonic seizures (HP:0002123) | 2.02718203 |
81 | Widely spaced teeth (HP:0000687) | 2.02107865 |
82 | Hypoplasia of the brainstem (HP:0002365) | 2.02038703 |
83 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.02038703 |
84 | Intention tremor (HP:0002080) | 1.99956652 |
85 | Psychosis (HP:0000709) | 1.98908872 |
86 | Hypothermia (HP:0002045) | 1.98263859 |
87 | Fetal akinesia sequence (HP:0001989) | 1.95900672 |
88 | Hyperthyroidism (HP:0000836) | 1.94651908 |
89 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.94464416 |
90 | Absent/shortened dynein arms (HP:0200106) | 1.94464416 |
91 | Megalencephaly (HP:0001355) | 1.91363082 |
92 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89889489 |
93 | Abnormality of secondary sexual hair (HP:0009888) | 1.87399422 |
94 | Abnormality of the axillary hair (HP:0100134) | 1.87399422 |
95 | Postural tremor (HP:0002174) | 1.86717694 |
96 | Genital tract atresia (HP:0001827) | 1.85977283 |
97 | Neuronal loss in central nervous system (HP:0002529) | 1.85877917 |
98 | Clumsiness (HP:0002312) | 1.84980178 |
99 | Ventricular fibrillation (HP:0001663) | 1.84916142 |
100 | Acute lymphatic leukemia (HP:0006721) | 1.84378575 |
101 | Rapidly progressive (HP:0003678) | 1.84374353 |
102 | Specific learning disability (HP:0001328) | 1.83192288 |
103 | Absent frontal sinuses (HP:0002688) | 1.83110317 |
104 | Vaginal atresia (HP:0000148) | 1.81536650 |
105 | Medial flaring of the eyebrow (HP:0010747) | 1.81327367 |
106 | Esotropia (HP:0000565) | 1.80037141 |
107 | Postural instability (HP:0002172) | 1.77539902 |
108 | Apathy (HP:0000741) | 1.77507816 |
109 | Stomach cancer (HP:0012126) | 1.77401940 |
110 | Aqueductal stenosis (HP:0002410) | 1.76986658 |
111 | Torticollis (HP:0000473) | 1.76523201 |
112 | Hypoventilation (HP:0002791) | 1.75908026 |
113 | Impaired vibratory sensation (HP:0002495) | 1.74376029 |
114 | Congenital primary aphakia (HP:0007707) | 1.74353773 |
115 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.72543115 |
116 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72228723 |
117 | Delusions (HP:0000746) | 1.70961979 |
118 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70615248 |
119 | Osteomalacia (HP:0002749) | 1.69848102 |
120 | Abnormal EKG (HP:0003115) | 1.67671710 |
121 | Impaired smooth pursuit (HP:0007772) | 1.67029471 |
122 | Curly hair (HP:0002212) | 1.66911931 |
123 | Increased mean platelet volume (HP:0011877) | 1.65595334 |
124 | Volvulus (HP:0002580) | 1.63790167 |
125 | Failure to thrive in infancy (HP:0001531) | 1.62188263 |
126 | Abnormality of macular pigmentation (HP:0008002) | 1.60970067 |
127 | Abnormal platelet volume (HP:0011876) | 1.58011335 |
128 | Sleep apnea (HP:0010535) | 1.53202856 |
129 | Status epilepticus (HP:0002133) | 1.52316900 |
130 | Bradykinesia (HP:0002067) | 1.51991907 |
131 | Neoplasm of the heart (HP:0100544) | 1.51973878 |
132 | Dyskinesia (HP:0100660) | 1.51947265 |
133 | Clonus (HP:0002169) | 1.49152503 |
134 | Long nose (HP:0003189) | 1.48885821 |
135 | Neoplasm of the thyroid gland (HP:0100031) | 1.47556883 |
136 | Gingival bleeding (HP:0000225) | 1.46917589 |
137 | Spontaneous hematomas (HP:0007420) | 1.46320614 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.95132595 |
2 | EPHA4 | 3.94756069 |
3 | MARK1 | 3.77941450 |
4 | CASK | 3.29264977 |
5 | MAP3K4 | 2.63868279 |
6 | MAP3K9 | 2.62955177 |
7 | PNCK | 2.57526207 |
8 | RIPK4 | 2.56900374 |
9 | MINK1 | 2.42789641 |
10 | MAP2K7 | 2.33908688 |
11 | PINK1 | 2.32684720 |
12 | NTRK1 | 2.10807403 |
13 | MAP3K12 | 1.98966016 |
14 | PLK2 | 1.95178392 |
15 | NTRK2 | 1.92954103 |
16 | FRK | 1.84194848 |
17 | MAPK13 | 1.82708131 |
18 | SIK2 | 1.76950363 |
19 | GRK5 | 1.69822815 |
20 | PAK6 | 1.65751074 |
21 | DAPK2 | 1.63835047 |
22 | MAP2K4 | 1.61277137 |
23 | TNIK | 1.50839281 |
24 | KSR2 | 1.45872745 |
25 | CDK5 | 1.44003672 |
26 | TEC | 1.43483201 |
27 | TIE1 | 1.36977208 |
28 | FGR | 1.36956282 |
29 | STK39 | 1.31663638 |
30 | KSR1 | 1.31083730 |
31 | TAOK3 | 1.27764452 |
32 | UHMK1 | 1.27674913 |
33 | FES | 1.26782643 |
34 | BMPR2 | 1.25538353 |
35 | CAMK2A | 1.23483950 |
36 | GRK7 | 1.20523574 |
37 | CAMK2B | 1.17133241 |
38 | ACVR1B | 1.15526458 |
39 | ARAF | 1.13980267 |
40 | PRPF4B | 1.11175305 |
41 | PRKCG | 1.09403805 |
42 | OXSR1 | 1.09121762 |
43 | MAP3K2 | 1.06232330 |
44 | PHKG1 | 1.05822972 |
45 | PHKG2 | 1.05822972 |
46 | PTK2B | 1.05194223 |
47 | CSNK1G2 | 1.04761600 |
48 | BCR | 1.04197442 |
49 | YES1 | 1.01847825 |
50 | SGK3 | 0.99721211 |
51 | STK38L | 0.99499219 |
52 | NME1 | 0.97499423 |
53 | DYRK2 | 0.96118093 |
54 | PKN1 | 0.95028243 |
55 | SGK494 | 0.93695019 |
56 | SGK223 | 0.93695019 |
57 | PRKCE | 0.91323633 |
58 | PAK3 | 0.90029497 |
59 | EPHA3 | 0.88637334 |
60 | MKNK2 | 0.88519458 |
61 | CDK14 | 0.88188302 |
62 | DAPK1 | 0.86936680 |
63 | CAMKK2 | 0.85843126 |
64 | DYRK1A | 0.85274256 |
65 | FGFR3 | 0.83674580 |
66 | WNK4 | 0.82754091 |
67 | CAMKK1 | 0.81614114 |
68 | LATS2 | 0.81486316 |
69 | TYRO3 | 0.80413476 |
70 | CDK18 | 0.79181422 |
71 | CAMK1G | 0.78246973 |
72 | CDK15 | 0.76385999 |
73 | ERBB2 | 0.75882668 |
74 | DMPK | 0.75754655 |
75 | CAMK2D | 0.73680953 |
76 | CSNK1G3 | 0.71725092 |
77 | WNK3 | 0.69660238 |
78 | RET | 0.69233760 |
79 | CDK19 | 0.68059255 |
80 | FER | 0.67806522 |
81 | PRKG2 | 0.67232595 |
82 | MAP3K1 | 0.67005209 |
83 | PRKD3 | 0.66919809 |
84 | MARK2 | 0.66597425 |
85 | MAPKAPK5 | 0.66494234 |
86 | CDK11A | 0.65863140 |
87 | ROCK2 | 0.65550749 |
88 | STK3 | 0.64426162 |
89 | LATS1 | 0.62461154 |
90 | PIK3CA | 0.62334728 |
91 | SGK1 | 0.61955447 |
92 | PDGFRB | 0.59203648 |
93 | STK11 | 0.58732471 |
94 | BMPR1B | 0.58053572 |
95 | CSNK1A1L | 0.56455202 |
96 | ADRBK1 | 0.56161552 |
97 | MAP3K13 | 0.55951240 |
98 | PRKCZ | 0.55901252 |
99 | SGK2 | 0.55484251 |
100 | FGFR2 | 0.55225389 |
101 | MKNK1 | 0.54489893 |
102 | ERBB3 | 0.54119763 |
103 | WNK1 | 0.54023544 |
104 | KIT | 0.52548292 |
105 | FYN | 0.52062012 |
106 | CDK3 | 0.50046068 |
107 | RPS6KA3 | 0.49838010 |
108 | HIPK2 | 0.49790259 |
109 | HCK | 0.49647192 |
110 | MAP2K1 | 0.48873719 |
111 | CAMK2G | 0.48057724 |
112 | ADRBK2 | 0.47239215 |
113 | MUSK | 0.46694690 |
114 | TAF1 | 0.43491832 |
115 | TRPM7 | 0.43191171 |
116 | CAMK1 | 0.43101257 |
117 | MAP3K6 | 0.42887547 |
118 | MAPK12 | 0.42464729 |
119 | CSNK1G1 | 0.42325533 |
120 | LIMK1 | 0.41705348 |
121 | PRKCH | 0.40907024 |
122 | RAF1 | 0.40658115 |
123 | RPS6KA2 | 0.39962255 |
124 | PRKG1 | 0.39732268 |
125 | PRKACG | 0.39016069 |
126 | NLK | 0.38612806 |
127 | MAPK10 | 0.38492490 |
128 | PRKACA | 0.38370265 |
129 | STK24 | 0.37913329 |
130 | JAK2 | 0.37900959 |
131 | STK38 | 0.36446184 |
132 | SIK3 | 0.35550603 |
133 | AKT3 | 0.34885443 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.77755419 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.72508487 |
3 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62979918 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.49598361 |
5 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48496764 |
6 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.46267078 |
7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.36580833 |
8 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.36070146 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.30498217 |
10 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13402029 |
11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08834695 |
12 | * Serotonergic synapse_Homo sapiens_hsa04726 | 2.00809314 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.00631100 |
14 | * Salivary secretion_Homo sapiens_hsa04970 | 1.89999581 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86918242 |
16 | * Long-term depression_Homo sapiens_hsa04730 | 1.83515430 |
17 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74443618 |
18 | * Renin secretion_Homo sapiens_hsa04924 | 1.73411255 |
19 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.72558670 |
20 | Axon guidance_Homo sapiens_hsa04360 | 1.69764733 |
21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69529727 |
22 | * Insulin secretion_Homo sapiens_hsa04911 | 1.62683299 |
23 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.54471213 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49904353 |
25 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47435491 |
26 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45310856 |
27 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37739135 |
28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35620202 |
29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35399143 |
30 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34975688 |
31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31690413 |
32 | * Gap junction_Homo sapiens_hsa04540 | 1.29299099 |
33 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28696272 |
34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25996333 |
35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20705868 |
36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18730396 |
37 | * Platelet activation_Homo sapiens_hsa04611 | 1.18671141 |
38 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16937076 |
39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12209625 |
40 | Phototransduction_Homo sapiens_hsa04744 | 1.09696016 |
41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04742634 |
42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02815392 |
43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02256517 |
44 | Glioma_Homo sapiens_hsa05214 | 0.98949892 |
45 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98605798 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98371043 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97708145 |
48 | * Melanogenesis_Homo sapiens_hsa04916 | 0.96560617 |
49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96329246 |
50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94782531 |
51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94600579 |
52 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91190291 |
53 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90099677 |
54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89225598 |
55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89141237 |
56 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.82148160 |
57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81405197 |
58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79339348 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78341063 |
60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77656296 |
61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77480108 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75756267 |
63 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72601652 |
64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71492728 |
65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71482954 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67274168 |
67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67136960 |
68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66978470 |
69 | Bile secretion_Homo sapiens_hsa04976 | 0.64241182 |
70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64174023 |
71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64116810 |
72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62897536 |
73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62683626 |
74 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62008380 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61877029 |
76 | Phagosome_Homo sapiens_hsa04145 | 0.59828047 |
77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58895772 |
78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58259296 |
79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57547520 |
80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55848880 |
81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55848622 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.55431059 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53952493 |
84 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53870229 |
85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53828570 |
86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52375900 |
87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52340802 |
88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51937368 |
89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51818595 |
90 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50720298 |
91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50143757 |
92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49696891 |
93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49676278 |
94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49324993 |
95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48473683 |
96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48259128 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47677068 |
98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46536319 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46004110 |
100 | Focal adhesion_Homo sapiens_hsa04510 | 0.45152747 |
101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43164167 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.43031936 |
103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42921400 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42903088 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.42165989 |
106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42115088 |
107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42077883 |
108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42045017 |
109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41846857 |
110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41063090 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40985856 |
112 | * Amoebiasis_Homo sapiens_hsa05146 | 0.40922301 |
113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39744353 |
114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37395551 |
115 | Mineral absorption_Homo sapiens_hsa04978 | 0.37286150 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36538352 |
117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36250780 |
118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36246079 |
119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33743015 |
120 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.33144677 |
121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33073914 |
122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32886098 |
123 | Melanoma_Homo sapiens_hsa05218 | 0.32366543 |
124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31370338 |
125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31221851 |